News

Featured News

  • 2020 |
  • 2019 |
  • 2018 |
  • 2017 |
  • View All
  • News | July 16, 2019

    Genentech inks its latest discovery deal — this time turning to RNA upstart Skyhawk

    Read More

    News | July 8, 2019

    Fattening the bankroll, Bill Haney adds cancer R&D powerhouse Merck to Skyhawk’s roster of partners out to drug RNA

    Read More

    News | June 10, 2019

    Aptinyx Reports Top-line Data from Phase 2 in Patients with Fibromyalgia

    Read More

    News | June 3, 2019

    Carisma Therapeutics Names Dr. Robert Petit As Chief Scientific Officer

    Read More

    News | May 27, 2019

    Carisma Therapeutics Featured in Nature Biotechnology’s Top Academic Spin-outs 2018

    Read More

    Press Release | May 14, 2019

    Precision BioSciences Appoints Christopher R. Heery, M.D., as Chief Medical Officer

    Read More

    Press Release | May 6, 2019

    Skyhawk Therapeutics Announces Agreement with Takeda for Neurodegenerative Diseases

    Read More

    News | April 9, 2019

    Pliant Therapeutics Reports Positive Results Of Phase 1 Clinical Study

    Read More

    News | March 1, 2019

    Genome editing company Precision proposes $100M IPO

    Read More

    News | January 16, 2019

    Aptinyx Reports Top-line Results from Phase 2 Clinical Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy

    Read More

    Press Release | January 4, 2019

    Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets

    Read More

    News | January 3, 2019

    Pliant Therapeutics Initiates Phase 1 Clinical Study of PLN-74809

    Read More

    News | December 18, 2018

    Palvella Therapeutics Announces $10 Million in Funding from Ligand Pharmaceuticals to Accelerate PTX-022 through Phase 2/3 Clinical Study in Pachyonychia Congenita

    Read More

    Press Release | December 18, 2018

    Entrada Therapeutics Raises $59 Million Series A to Advance Intracellular Biologics Platform

    Read More

    Press Release | December 13, 2018

    Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California

    Read More

    Press Release | December 6, 2018

    Precision BioSciences and Durham STEM Students Lead Launch of First Genome Editing Experiment Into Space

    Read More

    News | November 27, 2018

    Precision BioSciences Receives FDA Authorization to Initiate Clinical Study of Gene Edited Cancer Immunotherapy

    Read More

    News | November 20, 2018

    Pliant Therapeutics Receives FDA Orphan Drug Designation for Lead Program PLN-74809 in Primary Sclerosing Cholangitis

    Read More

    News | November 5, 2018

    Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering

    Read More

    Press Release | July 16, 2018

    Pliant Therapeutics Raises $62 Million in Series B Financing

    Read More